Century Therapeutics (IPSC) Earnings Date & Reports

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IPSC is expected to report earnings to fall 83.39% to -6 cents per share on May 08

Century Therapeutics IPSC Stock Earnings Reports

Q1'25

Est.

$-0.07

Q4'24

Est.

$-0.41

Q3'24

Beat

by $0.08

Q2'24

Beat

by $0.07

Q1'24

Beat

by $0.06

The last earnings report on March 19 showed earnings per share of -40 cents, beating the estimate of -41 cents. With 862.12K shares outstanding, the current market capitalization sits at 45.68M.

View a ticker or compare two or three

Compare

IPSC